[Clinical experience with the use of Tantum Rosa in cancer patients].
Chulkova
O V
OV
Demidova
L V
LV
Udovichenko
V I
VI
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001591:Benzydamine / Q000494:pharmacology / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D004334:Drug Administration Schedule; D005260:Female; D005833:Genital Neoplasms, Female / Q000150:complications / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D016896:Treatment Outcome; D014848:Vulvovaginitis / Q000188:drug therapy* / Q000209:etiology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D001591:Benzydamine
Opyt klinicheskogo primeneniia preparata Tantum Roza u onkologicheskikh bol'nykh.